VERVE THERAPEUTICS INC's ticker is and the CUSIP is 92539P901. A total of 2 filers reported holding VERVE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $33 | +266.7% | 2,500 | +400.0% | 0.00% | – |
Q2 2023 | $9 | -10.0% | 500 | -28.6% | 0.00% | – |
Q1 2023 | $10 | -97.1% | 700 | -96.0% | 0.00% | – |
Q4 2022 | $342 | -99.9% | 17,700 | +9.3% | 0.00% | -100.0% |
Q3 2022 | $556,000 | +768.8% | 16,200 | +285.7% | 0.00% | – |
Q2 2022 | $64,000 | +611.1% | 4,200 | +950.0% | 0.00% | – |
Q1 2022 | $9,000 | -69.0% | 400 | -50.0% | 0.00% | – |
Q4 2021 | $29,000 | – | 800 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SIMPLEX TRADING, LLC | 800 | $29,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |